Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

The American Kidney Fund’s ‘A Step Ahead of IgA Nephropathy’ Campaign Provides New Resources for Patients Living with IgA Nephropathy

ROCKVILLE, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Today, on IgA Nephropathy Awareness Day, the American Kidney Fund (AKF) proudly announces the creation of new educational resources for “A Step Ahead of IgA Nephropathy,” its newly updated educational awareness campaign. Developed by AKF with financial support from Novartis Pharmaceuticals Corporation (Novartis), this new educational content will help people living with IgA nephropathy and their families and caregivers better understand and manage this rare kidney disease.

IgA nephropathy is a rare disease that causes inflammation and damage to the kidneys. Over time, this damage reduces the organs’ ability to filter waste and fluid from the bloodstream, which can eventually lead to kidney failure. While there is no cure for IgA nephropathy, there are treatments to help treat the disease and slow the damage to the kidneys, potentially delaying or preventing kidney failure.

“We are very pleased to expand our IgA nephropathy campaign with new resources to help patients better understand this rare kidney disease,” said LaVarne A. Burton, AKF President and CEO. “With support from Novartis, we can provide more information and new tools to help IgAN patients stay ‘a step ahead’ of their diagnosis and live healthier lives.”

As part of this expansion, AKF has updated the “A Step Ahead of IgA Nephropathy” campaign webpage. The updates provide more information about proteinuria—protein in the urine. The new resources will also include a downloadable guide about proteinuria progression and an animated explainer video about proteinuria. To further share these resources and raise awareness of IgAN, AKF will also have an Instagram takeover day on June 18 for the campaign.

The “A Step Ahead of IgA Nephropathy” campaign is part of AKF’s ongoing work to increase awareness and understanding of rare kidney diseases and ensure people with rare conditions have access to critical resources. In 2024, AKF launched the Rare Kidney Disease Action Network (RKDAN), a new advocacy network working to ensure the voices of people living with rare kidney diseases are heard and amplified to impact change on the policy level. In its first year, RKDAN focused heavily on issues faced by people living with IgA nephropathy and brought 23 patients to Capitol Hill to advocate for two bills that would significantly improve research, treatment and diagnosis of rare kidney diseases.

###

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nonprofit with the greatest direct impact on people with kidney disease. AKF works on behalf of 1 in 7 Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. AKF fights for kidney health for all through programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and it has received 24 consecutive 4-Star ratings from Charity Navigator as well as the Platinum Seal of Transparency from Candid, formerly known as GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.


Nancy Gregory
American Kidney Fund
(240) 292-7077
ngregory@kidneyfund.org
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.